These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31081166)

  • 1. Evaluation of screening practices for low bone mass and prevalence of osteoporosis and fractures in people living with human immunodeficiency virus attending a sexual health clinic.
    Davidson N; Sowden D
    Intern Med J; 2019 Sep; 49(9):1119-1124. PubMed ID: 31081166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
    Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
    Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and associated factors of low bone mineral density in people living with HIV: a cross-sectional study.
    Shao Y; Sun J; Kong K; Zhang R; Zhang R; Liu L; Wang J; Shen Y; Wu L; Zheng Z; Sun M; Qi T; Wang Z; Tang Y; Sun J; Song W; Yang J; Xu S; Zhao B; Shan F; Qin A; Lu H; Chen J
    Arch Osteoporos; 2024 Jul; 19(1):56. PubMed ID: 38954143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of low bone mineral density and fragility fractures among HIV-infected patients at one Italian center after universal DXA screening: sensitivity and specificity of current guidelines on bone mineral density management.
    Mazzotta E; Ursini T; Agostinone A; Di Nicola AD; Polilli E; Sozio F; Vadini F; Pieri A; Trave F; De Francesco V; Capasso L; Borderi M; Manzoli L; Viale P; Parruti G
    AIDS Patient Care STDS; 2015 Apr; 29(4):169-80. PubMed ID: 25692868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced bone mineral density among HIV infected patients on anti-retroviral therapy in Blantyre, Malawi: Prevalence and associated factors.
    Chisati EM; Constantinou D; Lampiao F
    PLoS One; 2020; 15(1):e0227893. PubMed ID: 31935270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23.
    Chen KY; Wang CH; Lin TY; Chang CY; Liu CL; Hsiao YC; Hung CC; Wang NC
    J Microbiol Immunol Infect; 2019 Oct; 52(5):693-699. PubMed ID: 30293926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
    Bregigeon S; Galinier A; Zaegel-Faucher O; Cano CE; Obry V; Laroche H; Trijau S; Saout A; Poizot-Martin I
    AIDS; 2017 Jul; 31(11):1573-1577. PubMed ID: 28426535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
    Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
    Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protecting bone in long-term HIV positive patients receiving antiretrovirals.
    McGinty T; Mallon P
    Expert Rev Anti Infect Ther; 2016 Jun; 14(6):587-99. PubMed ID: 27189695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of osteopenia/osteoporosis in Turkish HIV/AIDS patients.
    Aydın OA; Karaosmanoglu HK; Karahasanoglu R; Tahmaz M; Nazlıcan O
    Braz J Infect Dis; 2013; 17(6):707-11. PubMed ID: 24076108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Risk Factors of Low Bone Mineral Density in HIV/AIDS Patients: A Chinese Cross-Sectional Study.
    Meng W; Chen M; Song Y; Zhang H; Xie R; Zhang F
    J Acquir Immune Defic Syndr; 2022 Jul; 90(3):360-368. PubMed ID: 35315797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of undisclosed osteoporosis in patients with minimal trauma fractures: a prospective cohort study.
    Scarvell JM; Van Twest MS; Stanton SF; Burski G; Smith PN
    Phys Sportsmed; 2013 May; 41(2):38-43. PubMed ID: 23703516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low bone mass prevalence, therapy type, and clinical risk factors in an HIV-infected Brazilian population.
    Pinto Neto LF; Ragi-Eis S; Vieira NF; Soprani M; Neves MB; Ribeiro-Rodrigues R; Miranda AE
    J Clin Densitom; 2011; 14(4):434-9. PubMed ID: 22051092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients.
    Casado JL; Bañon S; Andrés R; Perez-Elías MJ; Moreno A; Moreno S
    Osteoporos Int; 2014 Mar; 25(3):1071-9. PubMed ID: 24057480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
    Shaiykova A; Pasquet A; Goujard C; Lion G; Durand E; Bayan T; Lachâtre M; Choisy P; Ajana F; Bourdic K; Viget N; Riff B; Quertainmont Y; Cortet B; Boufassa F; Chéret A
    AIDS; 2018 Nov; 32(18):2689-2696. PubMed ID: 30234605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Metabolism in Men who Live with HIV Aged 50 years and Over: Impact of Infection Duration.
    Caglar B; Durcan E; Karaali R; Balkan II; Kaya SY; Yavuzer H; Konukoglu D; Aygun G; Saltoglu N; Bulut IN; Sonmezoglu K; Kadioglu P; Mete B; Tabak OF
    Curr HIV Res; 2024; 22(1):65-71. PubMed ID: 38279729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Prevalence of Low Bone Mineral Density and Substantial Bone Loss over 4 Years Among HIV-Infected Persons in the Era of Modern Antiretroviral Therapy.
    Escota GV; Mondy K; Bush T; Conley L; Brooks JT; Önen N; Patel P; Kojic EM; Henry K; Hammer J; Wood KC; Lichtenstein KA; Overton ET
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):59-67. PubMed ID: 26366785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?
    Hobusch GM; Noebauer-Huhmann I; Krall C; Holzer G
    Clin Orthop Relat Res; 2014 Nov; 472(11):3471-9. PubMed ID: 25015839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.
    Cazanave C; Dupon M; Lavignolle-Aurillac V; Barthe N; Lawson-Ayayi S; Mehsen N; Mercié P; Morlat P; Thiébaut R; Dabis F;
    AIDS; 2008 Jan; 22(3):395-402. PubMed ID: 18195566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.